Filing Details

Accession Number:
0001209191-23-033191
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-31 19:26:18
Reporting Period:
2023-05-26
Accepted Time:
2023-05-31 19:26:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Chinook Therapeutics Inc. KDNY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377258 Mariner William Greenman C/O Chinook Therapeutics, Inc.
400 Fairview Ave. No., 9Th Floor
Seattle WA 98109
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-26 3,300 $0.00 24,798 No 4 M Direct
Common Stock Disposition 2023-05-30 1,155 $23.30 23,643 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-05-26 3,300 $0.00 3,300 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-l trading plan previously adopted by the Reporting Person and represent shares by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.
  3. Each RSU represents a contingent right to receive one share of Issuer's common stock.
  4. 100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date.